Skip to main content
Fig. 3 | Chinese Medicine

Fig. 3

From: A novel microbial and hepatic biotransformation-integrated network pharmacology strategy explores the therapeutic mechanisms of bioactive herbal products in neurological diseases: the effects of Astragaloside IV on intracerebral hemorrhage as an example

Fig. 3

The potential targets of ASIV before and after microbial and hepatic biotransformation. There are 373 and 524 targets of ASIV before and after biotransformation, respectively. Two hundred and fifteen targets are common for ASIV, CA, and iso-CA (purple circles). The biotransformation results in 150 additional targets. ASIV Astragaloside IV, CA cycloastragenol, iso-CA 3-epi-cycloastragenol

Back to article page

Chinese Medicine

ISSN: 1749-8546

Contact us